Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00571493 · ClinicalTrials.gov registry record · Phase 1

VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell Lymphoma

A Phase 1 study of Mantle Cell Lymphoma and Non-Hodgkin's Lymphoma, sponsored by University of Nebraska.

Completed
Registry status
Phase 1
Development phase
42
Enrollment target
1
Study location

NCT00571493 is a Phase 1 study of Mantle Cell Lymphoma and Non-Hodgkin's Lymphoma that has completed, run by University of Nebraska. The registered enrollment target is 42 participants, below the 104-participant average among 102 other Mantle Cell Lymphoma trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00571493, a Phase 1 study of Mantle Cell Lymphoma and Non-Hodgkin's Lymphoma, has completed, sponsored by University of Nebraska.

COMPLETED
Registry status
Phase 1
Development phase
42 participants
Enrollment target
1
Study location

Study Summary

This is a Phase I/II trial designed to study the toxicity and Maximum Tolerated Dose (MTD) of bortezomib in combination with BEAM (carmustine (BCNU), etoposide, cytarabine, melphalan) and autologous hematopoietic stem cell transplantation (ASCT) and to obtain a preliminary estimate of the response rate to this combination.

Conditions Studied

Mantle Cell Lymphoma Non-Hodgkin's Lymphoma

Interventions

  • DRUG Bortezomib
  • DRUG BEAM (carmustine (BCNU), etoposide, cytarabine, melphalan)

Study Locations (1)

Nebraska

  • University of Nebraska Medical Center - Omaha

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2006-04-14
Est. Completion 2014-11-01
Phase Phase 1

Sponsor

University of Nebraska

407 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00571493

The ClinicalTrials.gov registry entry for NCT00571493 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 104-participant average among 102 other Mantle Cell Lymphoma trials with a reported enrollment target (60% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Mantle Cell Lymphoma appearing as the primary indexed condition, and to 2 interventions - of which Bortezomib is the first listed.

NCT00571493 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT00571493 about?

NCT00571493 is a clinical study titled "VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell Lymphoma". This is a Phase I/II trial designed to study the toxicity and Maximum Tolerated Dose (MTD) of bortezomib in combination with BEAM (carmustine (BCNU), etoposide, cytarabine, melphalan) and autologous hematopoietic stem cell transplantation (ASCT) and to obtain a preliminary estimate of the response r...

What is the current status of trial NCT00571493?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 42 participants. The study started on 2006-04-14. Estimated completion is 2014-11-01.

What conditions does trial NCT00571493 study?

This clinical trial studies the following conditions: Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma.

What interventions are being tested in trial NCT00571493?

The interventions under investigation include: Bortezomib (DRUG), BEAM (carmustine (BCNU), etoposide, cytarabine, melphalan) (DRUG).

Who is sponsoring clinical trial NCT00571493?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00571493 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Mantle Cell Lymphoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Mantle Cell Lymphoma

All registered trials for this condition

Non-Hodgkin's Lymphoma

All registered trials for this condition

Nebraska

All trials with a study site in Nebraska

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.